Mixed cytokine profile during active cutaneous leishmaniasis and in natural resistance

Frontiers in Bioscience

Volumn 12, Issue 3, 2007, Pages 839-849

  Baratta Masini, Ariane ^a,b   Teixeira Carvalho, Andréa ^a,d   Malaquias, Luiz Cosme Cotta ^c   Mayrink, Wilson ^b   Martins Filho, Olindo Assis ^a   Corrêa Oliveira, Rodrigo ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSIDADE VALE DO RIO DOCE   (Brazil)

^d FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Cytokine; Human cutaneous leishmaniasis; Nitric oxide; T cells

Indexed keywords

EID: 34249785418     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2106     Document Type: Review

References (42)

1. Liew F.Y & C. A. O'Donnell: Immunology of leishmaniasis. Adv Parasitol 32, 161-259 (1993)
2. Llanos-Cuentas E.A, C. C Cuba, A. C. Barreto & P. D. Mardsen: Clinical characteristics of human Leishmania braziliensis infection. Trans R Soc Trop Med Hyg 78, 845-846 (1984)
3. Jones T. C, W. D. Johnson, A. C. Barreto, E. Lago, R. Badaro, B. Cerf, S. G. Reed, E. M. Netto, M. S. Tada & T. F. Franca: Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 156, 73-83 (1987)
4. Da-Cruz A. M, R. Bittar, M. Mattos, M. P. Oliveira-Netto, R. Nogueira, V. Pinho-Ribeiro, R. B. AzeredoCoutinho & S. G. Coutinho: T-cell-mediated immune response in patients with cutaneous or mucosal leishmaniasis: Long-term evaluation after therapy. Clin Diag Lab Immunol 9, 251-256 (2002)
5. Heinzel F. P, M. D. SadicK, S. S. Mutha & R. M. Locksley: Production of interferon-gamma, interleukin-2, interleukin-4 and interleukin-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 88, 7011-7015 (1991)
6. Scott P: Host and parasite factors regulating the development of CD4+ subsets in experimental cutaneous leishmaniasis. Res Immunol 142, 32-36 (1991)
7. Coffman R. L, R. Chaletalin, L. M. C. C. Leal & K. Varkila: Leishmania major infection in mice: a model system for the study of CD4+ T-cell subset differentiation. Res Immunol 142, 36-40 (1991)
8. Sacks D. L & N. Noben-Trauth: The immunology of susceptibility and resistance to Leishmania major in mice. Nat Ver Immunol 2, 845-858 (2002)
9. Barral A, M. Barral-Netto, E. C. Yong, C. E. Brownell, D. R. Twardzik & S. G. Reed: Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci USA 90, 3442-3446 (1993)
10. Ribeiro-de-Jesus A, R. P. Almeida, H. Lessa, O. Bacellar & E. M. Carvalho: Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 31, 143-148 (1998)
11. Rocha P. N, R. P. Almeida, O. Bacellar, A. R. Jesus, D. Correia-Filho, A. C. Filho, A. Barral, R. L. Coffman, E. M. Carvalho: Down-regulation of Th1 type response in early human American cutaneous leishmaniasis. J Infec Dis 180, 1731-1734 (1999)
12. Coutinho S. G, M. P. Oliveira, A. M. Da-cruz, P. De-Luca, S. C. F. Mendonça, A. L. Bertho, L. Soong & D. McMahon-Pratt: T-cell responsiveness of American cutaneous leismaniasis patients to purified Leishmania pifanoi amastigotes antigens and Leishmania braziliensis promastigotes antigens: Immunologic patterns associated with cure. Exp Parasitol 84, 144-155, (1996)
13. Coutinho S. G, A. M. Da-Cruz, A. L. Bertho, M. A. Santiago & P. De-Luca: Immunologic patterns associated with cure in human American cutaneous leishmaniasis. Braz J Med Biol Res 31, 139-142 (1998).
14. Da Cruz A. M, F. Conceiçâo-Silva, A. L. Bertho & S. G. Coutinho: Leishmania - reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infect Immun 62, 2614-2618 (1994)
15. Carvalho E. M, D. Correia-Filho, O. Bacellar, R. P. Almeida, H. Lessa & H. Rocha: Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. Am J Trop Med Hyg 53, 273-277 (1995)
16. Mendonça S. C. F, P. De-Luca, W. Mayrink, T. G. Restom, F. Conceição-Silva, A. M. Da-Cruz, A. L. Bertho, C. A. Costa, O. Genaro, V. P. C. P. Toledo & S. C. Coutinho: Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against american tegumentary leishmaniasis. Am J Trop Med Hyg 53, 195-201 (1995)
17. De-Luca P. M, W. Mayrink, C. R. Alve, S. G. Coutinho, M. P. Oliveira, A. L. Bertho, V. P. C. P. Toledo, C. A. Costa, O. Genaro & S. C. F. Mendonça: Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against american tegumentary leishmaniasis. Vaccine 17, 1179-1185 (1999)
18. Nathan C. F, H. W. Murray, M. E. Wiebe & Y. Rubin: Identification of interferon gamma as the lymphokine that activates human macrophages oxidative metabolism and antimicrobial activity. J Exp Med 158, 670-689 (1983)
19. Liew F. Y, C. Parkinson, S. Millor, A. Severn & M. Carrier: Tumor necrosis factor (TNF-alpha) in leishmaniasis. 1. TNF-alpha mediates host protection against cutaneous leishmaniasis. Immunology 69, 570-573 (1990)
20. Liew F. Y: Regulation of nitric oxide synthesis in infectious and autoimmune disease. Immunol Lett 43, 95-98 (1994)
21. Nathan C & M. U. Shiloh: Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 97, 8841-8848 (2000)
22. Brunet L. R: Nitric oxide in parasitic infection. Int Immunopharmacol 1, 1467-1475 (2001)
23. Carvalho E. M, A. Barral, J. M. Costa, A. Bittencourt & P. Mardsen: Clinical and immunophatological aspects of disseminated cutaneous leishmaniasis. Acta Trop 56, 315-325 (1994)
24. Badaró R, T. Jones, E. M. Carvalho, D. Sampaio, S. G. Reed, A. Barral, R. Teixeira & W. D. Jr. Johnson: New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 154, 1003-1011 (1986)
25. Davies C. R, E. A. Llanos-Cuentas, S. D. Pyke & C. Dye: Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity. Epidemiol Infect 114, 297-318 (1995)
26. Costa C. A, V. P. C. P. Toledo, O. Genaro, P. Williams & W. Mayrink: Montenegro skin test - evaluation of the composition and stability of the antigen preparation. Mem Inst Oswaldo Cruz 91, 193-194 (1996)
27. Lowry O. H, N. J. Rosenbrough, A. L. Fair & R. J. Randall: Protein measurement with the folin phenol reagent. JBiol Chem 193, 265-275 (1951)
28. 15N) nitrite in biological fluids. Anal Biochem 126, 131-138 (1982)
29. Moshage H, B. Kok, J. R. Huizenga & P. L. Jansen: Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 41, 892-896 (1995)
30. Archer S: Measurement of nitric oxide in biological models. FASEB J 7, 349-360 (1993)
31. Bottrel R. L. A, W. O. Dutra, F. A. Martins, B. Gontijo, E. Carvalho, M. Barral-Netto, A. Barrai, R. P. Almeida, W. Mayrink, R. Locksley & K. J. Gollob: Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble leishmania antigen in human cutaneous leishmaniasis. Infect Immun 69, 3232-3239 (2001)
32. Kemp K, T. G. Theander, L. Hviid, A. Garfar, A. Kharazmi & M. Kemp: Interferon-gamma and tumor necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis. Scan J Immunol 49, 655-659 (1999)
33. Green S. J, R. M. Crawford, J. T. Hockmeyer, M. S. Meltzer & C. A. Nacy: Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol 145, 4290-4997 (1990)
34. Sadick M. D, R. M. Locksley, C. Tubbs & H. V. Raft: Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. J Immunol 136, 655-661 (1986)
35. Erel O, A. Kocyigit, V. Bulut & M. S. Gurel: Reactive nitrogen and oxygen intermediates in patients with cutaneous leishmaniasis. Mem Inst Oswaldo Cruz 94, 179-183 (1999)
36. Qadoumi M, I. Becker, N. Donhauser, M. Röllinghoff & C. Bogdan: Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis. Infect Immun 70, 4638-4642 (2002)
37. Bacellar O, H. Lessa, A. Schriefer, P. Machado, A. Ribeiro-de-Jesus, W. O. Dutra, K. J. Gollob & E. M. Carvalho: Up-regulation of Thl-type responses in mucosal leishmaniasis patients. Infect Immun 70, 6734-6740 (2002)
38. Pompeu M. M. L, C. Brodskyn, M. J. Teixeira, J. Clarêncio, J. Van Weyenberg, I. C. B. Coelho, S. A. Cardoso, A. Barral & M. Barral-Netto: Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers. Infect Immun 69, 7453-7460 (2001)
39. Antonelli L. R. V, W. O. Dutra, R. P. Almeida, O. Bacellar & K. J. Gollob: Antigen specific correlations of cellular immune responses in human leishmaniasis suggest mechanisms for immunoregulation. Clin Exp Immunol 136, 341-348 (2004)
40. Follador I, C. Araújo, O. Bacellar, B. C. Araújo, P. L. Carvalho, P. R. Almeida & E. M. Carvalho: Epidemiologic and Immunologic findings for the subclinical form of Leishmania braziliensis infection. Clin Infec Dis 34, e54-e58 (2002)
41. Correa-Oliveira R, I. R. Caldas & G. Gazzinelli: Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol Today 16, 397-399 (2000)
42. Gomes J. A, L. M. Bahia-Oliveira, O. A. Martins-Filho, G. Gazzinelli & R. Correa-Oliveira: Evidence that development of severe cardiomyopathy in human Chaga's disease is due to a Th1-specific immune response. Infect Immun 71, 1185-1193 (2003)